Marca Nominativa depositada no INPI em 20/05/2020 por Qiagen GmbH, processo nº 501552949, nas classes 01, 05, 09, 10, 42, 44. Registro em vigor até 20/05/2030.
| Número do processo | 501552949 |
|---|---|
| Situação | Registro de marca em vigor (Madri) |
| Apresentação | Nominativa |
| Natureza | Madri Produto/Serviço |
| Data do depósito | 20/05/2020 |
| Data da concessão | 08/09/2021 |
| Vigência até | 20/05/2030 |
| Titular | Qiagen GmbH |
| CNPJ/CPF do titular | — |
| UF · País | — · DE |
Reagents, enzymes and buffer solutions for scientific and/or medical research use for marking, amplifying and quantifying of biopolymers, in particular analysis of nucleic acids; reagents for scientific and medical research use; chemical solutions and preparations consisting of pre-mixed reactants and reagents for scientific and research use in connection with marking amplifying, and quantifying /or for the analysis of biopolymers, in particular analysis of nucleic acids; reagent kits comprising biological protein, DNA primers, polymerase or buffers for scientific and medical research; chemical, biochemical and biotechnological products for commercial and scientific use, namely, buffer solutions, nucleic acids, nucleic acid derivatives and proteins for chemical analysis.;
Diagnostic preparations for medical purposes; diagnostic preparations for veterinary purposes; diagnostic preparations for humans for medical purposes; preparations for medical and veterinary purposes, in particular diagnostics, for marking, amplifying, quantification and/or for the analysis of biopolymers, in particular nucleic acids; chemical, biochemical and biotechnological preparations for medical and veterinary purposes, in particular instruments, microfluidic plates, reagents, enzymes and buffer solutions for marking, amplifying, quantification and/or for the analysis of biopolymers, in particular nucleic acids, in particular reagents, enzymes and buffer solutions for nucleic acid amplification; kits containing preparations for medical and veterinary diagnostic purposes, in particular for marking, amplifying, quantification and/or for the analysis of biopolymers, in particular nucleic acids, in particular reagents, enzymes and buffer solutions for nucleic acid amplification; chemical reagents for medical purposes; cartridges containing medical diagnostic reagents for use in Polymerase Chain Reaction (PCR) or digital Polymerase Chain Reaction (PCR) instruments; medical diagnostic assays for testing of body samples, including bodily fluids and tissue in the detection, monitoring, and prediction of disease or other conditions, disease states, hormone level, drug level, drug response, organ function effectiveness, and clinical response; diagnostic preparations for medical purposes; diagnostic test kits comprised of medical diagnostic reagents and assays for testing in the field of medical diagnostics.;
Scientific apparatus, instruments and equipment for scientific research, diagnostic analysis (non-medical), chemical analysis, clinical analysis and industrial use, including DNA and RNA testing apparatus, and accessories, namely, microplates, Society of Biomolecular Screening (SBS) standardized laboratory equipment including microplates, plate holders and plate seals, computer software for operation and maintenance of scientific apparatus, instruments and equipment; computer software for creating experimental profiles, providing experimental reports and reports of apparatus performance verification; digital Polymerase Chain Reaction (dPCR) instruments; apparatus detecting the amount of nucleic acids binding fluorescence dye or the amount of fluorescence dye released from nucleic acid binding probe for laboratory or research use; computer software and hardware for medical diagnostic instrument for digital Polymerase Chain Reaction (dPCR) computer software and hardware for processing diagnostic medical testing or laboratory data; computer hardware and software for use in laboratory management, namely, database management, experimental data management, information management; computer software and hardware for data analysis for use in laboratories; computer software and hardware for identifying and analyzing characteristics of nucleic acid sequence and nucleic acid; computer software and hardware for use in gene analysis, human identification, microbial identification in the field of life science research and biological technology development; laboratory apparatus and instruments for gene analysis, human identification, microbial identification in the field of life science research and biological technology development; laboratory apparatus for genotyping, gene expression analysis, copy number variation, mutation detection and direct quantification of nucleic acids; scientific apparatuses, instruments and devices, as well as their parts and components, in particular microfluidic cartridges, microfluidic plates, digital Polymerase Chain Reaction (dPCR) plates, digital Polymerase Chain Reaction (dPCR) microfluidic plates, and covers for digital Polymerase Chain Reaction (dPCR) plates, that can be used in chemical analysis, biological analysis or patterning for scientific, laboratory or medical research use; computer software for use in database management and electronic storage of data for scientific and medical research; computer software for scientific analysis of nucleic acids; analysis software and database management software for use in biopharmaceutical research; software for use in detecting cancer and infectious disease; software for use in operating digital polymerase chain reaction (dPCR) instruments; polymerase chain reaction (PCR) instruments for use in scientific research, namely, laboratory apparatus and instruments for the partitioning of Polymerase Chain Reaction (PCR) reactions, amplifying DNA using polymerase chain reaction (PCR); scientific research instruments for use in measuring and quantifying copy number of DNA, genotyping, gene expression analysis, mutations, and for direct quantification of nucleic acids; non-medical instruments, for marking, amplifying and quantifying of biopolymers, in particular analysis of nucleic acids, for use in Polymerase Chain Reaction (PCR) methods.;
Apparatus for medical and veterinary diagnostic analysis and determination of medical and veterinary conditions, namely, DNA and RNA testing apparatus; medical and veterinary equipment for diagnostic purposes; clinical medical laboratory apparatus and analytical instruments, namely digital Polymerase Chain Reaction (d PCR) instruments for use in-vitro and in-vivo diagnostics; medical devices for detection of infectious disease, namely, digital polymerase chain reaction (dPCR) platforms; medical devices for use in pre-natal screenings, namely, digital polymerase chain reaction (dPCR) platform; medical devices, namely, digital polymerase chain reaction (dPCR) instruments for use in detecting, diagnosing and treating cancer and infectious disease, namely, digital polymerase chain reaction (dPCR) platform; medical devices, namely, digital polymerase chain reaction (dPCR) instruments for use in pre-natal screenings, namely, digital polymerase chain reaction (PCR) platform; medical devices, namely, instruments for use in measuring and quantifying copy number of DNA for medical diagnostic purposes, namely, digital polymerase chain reaction (dPCR) platform; microfluidic plates for use as medical apparatus.;
Scientific research for others in the fields of genetics, biology and biochemistry; scientific diagnostic services for others in the fields of DNA, RNA detection and analysis; scientific and research services for others utilising digital Polymerase Chain Reaction (PCR) platforms; scientific consultancy with regard to the establishment of a dPCR laboratory; research and development services in the field of bioanalytics, namely the development of pharmaceutical, medical, forensic, veterinary and agricultural chemicals and biochemicals; genomic analysis, assaying, imaging and profiling; chemical screening analysis; genetic medical testing and analytic services.;
Testing services, namely, quantifying DNA and RNA for medical, diagnostic and treatment purposes; rental of digital Polymerase Chain Reaction (PCR) apparatus; RNA or DNA analysis for cancer diagnosis and prognosis; medical services, in particular medical analysis in connection with the treatment of individuals; providing information in the fields of medicine, veterinary medicine and pharmaceuticals; health centers, namely, genetic centers providing medical diagnostic, preventive and curative therapy services for genetic disorders, cancer treatment centers, rare disease treatment centers, children's hospitals and women's hospital; medical clinics; gene therapy services in the field of oncology, infertility, prenatal diagnostics, carrier testing, and genetically inherited diseases; medical laboratory services for the analysis of samples taken from patients.;
Receba um e-mail a cada novo despacho publicado na RPI para o processo 501552949 — exigência, oposição, deferimento, prazo de pagamento — e quando alguém depositar uma marca parecida.
Monitorar esta marca Ver marcas parecidas4 despacho(s) publicado(s) na Revista da Propriedade Industrial.